Palladium(II) complexes obtained from 3,4-bis(cyanamido)cyclobutane-1,2-dione dianion

Three palladium(II) complexes have been synthesized, using 3,4-bis(cyanamido) cyclobutane-1,2-dione dianion (3,4-bis(cyanamido)squarate or 3,4-NCNsq²⁻): [Pd(en)(3,4-NCNsq)] · 1.5H₂O (1) (en=1,2-diaminoethane), [Pd(en)(3,4-(NC(O)NH₂)sq)] · 0.5H₂O (2) and K₃Na[Pd₂(3,4-(NCN)₂sq)₄] · 5H₂O (3). Complex 1 has been characterized by elemental analysis, IR and ¹³C NMR spectroscopies. Complexes 2 and 3 have been characterized by single-crystal X-ray diffraction. In complex 2, the unusual hydration of the cyanamido ligand was observed, it proceeds in the coordination sphere of the palladium and leads to a chelating urea squarate ligand. Complex 3 is an anionic dinuclear complex containing four bridging cyanamido squarate ligands. In complexes 2 and 3, the 3,4-NCNsq²⁻ ligand (hydrated or not) is, for the first time, coordinated to the metal atom by the two amido nitrogen atoms, either in a chelating mode (complex 2) or in a bridging mode giving a short Pd ? Pd distance of 2.8866(15) Å (complex 3). Electrochemical studies in acetonitrile and dmf solutions have been performed on complexes 1 and 3.     

Triterpenoidal saponins of Pulsatilla koreana roots

Sixteen (1-16) triterpenoidal saponins were isolated from the roots of Pulsatilla koreana, of which four were determined as the previously unknown 23-hydroxy-3β-[(O-α-L-arabinopyranosyl)oxy]lup-20(29)-en-28-oic acid 28-O-β-D-glucopyranosyl ester (1), 23-hydroxy-3β-[(O-α-L-rhamnopyranosyl-(1 → 2)-α-L-arabinopyranosyl)oxy]lup-20(29)-en-28-oic acid 28-O-β-D-glucopyranosyl ester (2), 3β-[(O-α-L-rhamnopyranosyl-(1 → 2)-α-L-arabinopyranosyl)oxy]lup-20(29)-en-28-oic acid 28-O-β-D-glucopyranosyl-(1 → 6)-β-D-glucopyranosyl ester (3), and 3β-[(O-α-L-rhamnopyranosyl-(1 → 2)-O-[β-D-glucopyranosyl-(1 → 4)]-α-L-arabinopyranosyl)oxy]lup-20(29)-en-28-oic acid 28-O-α-L-rhamnopyranosyl-(1 → 4)-O-β-D-glucopyranosyl-(1 → 6)-β-D-glucopyranosyl ester (4), respectively, based on spectroscopic analysis. The inhibition of the lipopolysaccharide-induced nitric oxide production of sixteen isolated compounds was evaluated in RAW 264.7 cells at concentrations ranging from 1 μM to 100 μM.     

One-dimensional nickel and cobalt phthalate coordination polymers incorporating the kinked dipodal organodiimine 4,4′-dipyridylamine: Hydrothermal synthesis, structural characterization and thermal properties

Hydrothermal synthesis has afforded a family of three structurally related metal phthalate (pht) 1-D coordination polymers incorporating the kinked dipodal organodiimine 4,4′-dipyridylamine (dpa), with a general formulation of [L₂M(dpa)₂M(H₂O)₄] · H₂O (L = pht, M = Co, 1, M = Ni, 2; L = 4-methylphthalate (4-mpht), M = Co, 3). Single crystal X-ray diffraction of 1 and 2 revealed the presence of one-dimensional (1-D) polymeric chains consisting of [M(H₂O)₄]²⁺ and [M(pht)₂]²⁻ subunits linked through dpa tethers. These chains in turn conjoin into pseudo 2-D layers and 3-D networks via extensive supramolecular hydrogen bonding pathways. An extremely similar structure is observed for 3 despite the presence of the bulkier methyl group substituent. 1-3 were further characterized via infrared spectroscopy and elemental and thermogravimetric analysis. 1-3 represent the first dicarboxylate coordination polymers incorporating dpa tethering ligands.     

Squarato-bridged polymeric networks of iron(II) with N-donor coligands: Syntheses, crystal structures and magnetic properties

Two new squarato-bridged Fe(II) polymeric networks of molecular formula [Fe(squarate)(bpp)₂(H₂O)₂] (1) and [Fe(squarate)(bpee)(H₂O)₂] (2) [bpp = 1,3-bis(4-pyridyl)propane; bpee = 1,2-bis(4-pyridyl)ethylene; ] have been synthesized and characterized by single-crystal X-ray diffraction studies and low temperature (300-2 K) magnetic measurements. Complex 1 is a 1D coordination chain of Fe(H₂O)₂ units connected by μ-O,O″ squarate dianions with monocoordinated bpp ligands dangling from the polymer. These 1D chains ultimately transform to a thick 2D layer through π-π interaction of pyridyl rings as well as through hydrogen bonds. Whereas structural determination of complex 2 reveals an inclined interpenetrated 3D architecture. Magnetic data for both the complexes 1 and 2 have been fitted using the Fisher formula for S = 2 system and show antiferromagnetic coupling for both the complexes. The best fit parameters are J = −0.40 cm⁻¹, g = 2.30 and R = 0.01 for complex 1 and J = −0.49 cm⁻¹, g = 2.08 and R = 1.9 × 10⁻³ for complex 2.     

Acylated triterpene saponins from the roots of Securidaca longepedunculata

Four triterpene saponins, 3-O-β-d-glucopyranosylpresenegenin 28-O-β-d-apiofuranosyl-(1 → 3)-β-d-xylopyranosyl-(1 → 4)-[β-d-apiofuranosyl-(1 → 3)]-α-l-rhamnopyranosyl-(1 → 2)-{4-O-[(E)-3,4,5-trimethoxycinnamoyl]}-β-d-fucopyranosyl ester, 3-O-β-d-glucopyranosylpresenegenin 28-O-β-d-apiofuranosyl-(1 → 3)-β-d-xylopyranosyl-(1 → 4)-[β-d-apiofuranosyl-(1 → 3)]-α-l-rhamnopyranosyl-(1 → 2)-[(6-O-acetyl)-β-d-glucopyranosyl-(1 → 3)]-{4-O-[(E)-3,4,5-trimethoxycinnamoyl]}-β-d-fucopyranosyl ester, 3-O-β-d-glucopyranosylpresenegenin 28-O-β-d-apiofuranosyl-(1 → 3)-β-d-xylopyranosyl-(1 → 4)-[β-d-apiofuranosyl-(1 → 3)]-α-l-rhamnopyranosyl-(1 → 2)-[β-d-galactopyranosyl-(1 → 3)]-{4-O-[(E)-3,4,5-trimethoxycinnamoyl]}-β-d-fucopyranosyl ester, and 3-O-β-d-glucopyranosylpresenegenin 28-O-β-d-apiofuranosyl-(1 → 3)-[α-l-arabinopyranosyl-(1 → 4)]-β-d-xylopyranosyl-(1 → 4)-[β-d-apiofuranosyl-(1 → 3)]-α-l-rhamnopyranosyl-(1 → 2)-{4-O-[(E)-3,4,5-trimethoxycinnamoyl]}-β-d-fucopyranosyl ester, were isolated from the roots of Securidaca longepedunculata, together with three known compounds. Their structures were established mainly by 2D NMR techniques and mass spectrometry.     

Inhibitory effect of schisandrin on spontaneous contraction of isolated rat colon

This study examined the effect of schisandrin, one of the major lignans isolated from Schisandra chinensis, on spontaneous contraction in rat colon and its possible mechanisms. Schisandrin produced a concentration-dependent inhibition (EC₅₀ = 1.66 μM) on the colonic spontaneous contraction. The relaxant effect of schisandrin could be abolished by the neuronal Na⁺ channel blocker tetrodotoxin (1 μM) but not affected by propranolol (1 μM), phentolamine (1 μM), atropine (1 μM) or nicotine desensitization, suggesting possible involvement of non-adrenergic non-cholinergic (NANC) transmitters released from enteric nerves. N^ω-nitro-l-arginine methyl ester (100-300 μM), a nitric oxide synthase inhibitor, attenuated the schisandrin response. The role of nitric oxide (NO) was confirmed by an increase in colonic NO production after schisandrin incubation, and the inhibition on the schisandrin responses by soluble guanylyl cyclase inhibitor 1H-[1,2,4] oxadiazolo[4,3-α]-quinoxalin-1-one (1-30 μM). Non-nitrergic NANC components may also be involved in the action of schisandrin, as suggested by the significant inhibition of apamin on the schisandrin-induced responses. Pyridoxal phosphate-6-azo(benzene-2,4-disulfonic acid) tetrasodium salt hydrate (100 μM), a selective P2 purinoceptor antagonist, markedly attenuated the responses to schisandrin. In contrast, neither 8-cyclopentyl-1,3-dipropylxanthine, an antagonist for adenosine A₁ receptors, nor chymotrypsin, a serine endopeptidase, affected the responses. All available results have demonstrated that schisandrin produced NANC relaxation on the rat colon, with the involvement of NO and acting via cGMP-dependent pathways. ATP, but not adenosine and VIP, likely plays a role in the non-nitrergic, apamin-sensitive component of the response.     

Reactions of ketones with coordinated nitriles on β-diketonato ruthenium complexes leading to formation of compounds with new carbon-carbon bonds

The reactions of [Ru(acac)₂(CH₃CN)₂] with four ketones (acetone, ethyl methyl ketone, acetylacetone and monochloroacetone), and the reactions of [Ru(acac)₂(C₆H₅CN)₂] with two ketones (acetone and ethyl methyl ketone) yielded six novel compounds of β-ketiminato ruthenium complexes: [Ru(acac)₂(mhmk)], [Ru(acac)₂(ehmk)], [Ru(acac)₂(mAmk)], [Ru(acac)₂(mClmk)], Ru(acac)₂(mhbk)], and [Ru(acac)₂(ehbk)] (mhmk = 4-iminopentane-2-one mono anion, ehmk = 5-iminohexane-3-one mono anion, mAmk = 3-(1-iminoethyl)-2,4-pentanedione mono anion, mClmk = 3-chloro-4-imino-pentane-2-one mono anion, mhbk = 1-phenyl-1-iminobutane-3-one mono anion, ehbk = 1-phenyl-1-iminopentane-3-one mono anion). All the new complexes have been characterized by elemental analyses, ¹H NMR, MS and electronic spectral data. Crystal and molecular structures for the six β-ketimine complexes have been solved by single crystal X-ray diffraction studies. A mechanism involving the attack of ketones on the coordinated nitrile has been proposed. The electrochemical redox behavior of the β-ketimine complexes has been elucidated.     

Reversible ring opening and closure reactions of the triazine ligands derived from 1-phenylazo-2-naphthylamine and pyridine-2-aldehyde or quinoline-2-aldehyde - structure and reactivity of the palladium (II) complexes

New ligands containing a heterocyclic ring, L¹ (1-anilino-2-(2-pyridyl)-naphth[1,2-d]imidazol-1-io-3-ide), L² (2-phenyl-3-(2-pyridyl)-3,4-dihydro-naphtho[2,1-e][1,2,4]triazin-1-io-4-ide), and L³ (1-anilino-2-(2-quinolyl)-naphth[1,2-d]imidazol-1-io-3-ide), and their palladium (II) complexes have been prepared. Structures of the ligands and the complexes were determined by X-ray crystallography. The mononuclear square-planar complexes of [PdCl₂(Lⁿ)] (n = 1 (1), n = 2 (2) and n = 3 (3)) had didentate Lⁿ (n = 1-3) ligands. The Lⁿ (n = 1-3) ligands were stable and their absorption spectra did not change in dichloromethane and methanol. On the other hand, the absorption spectrum of [PdCl₂(L²)] (2) in dichloromethane changed rapidly when methanol was added to the solution, and [PdCl(L^4b)] (5) (L^4b = N-[methoxy(2-pyridyl)methyl]-1-(phenylazo)-2-naphthylamide) was obtained from the concentrated reaction mixture. In this reaction, the dihydrotriazine ring of the didentate L² ligand in complex 2 opened and the resulting tridentate L^4b ligand coordinated to the Pd atom in complex 5. When an excess amount of (ⁿBu)₄NCl was added to complex 5 in dichloromethane, the absorption spectrum reverted to that of complex 2. Thus, the reversible ring opening and closure reactions of the coordinating dihydrotriazine ligand were observed. We also prepared [PdCl₂(L⁵)] (9) (L⁵ = 1-(phenylazo)-N-[1-(2-pyridyl)ethylidene]-2-naphthylamine) and determined the structure. It is noted that neither the ring closure reaction nor the coordination of the azo nitrogen atom of the L⁵ ligand occurred in complex 9.     

Syntheses, structural and spectroscopic investigation (IR, NMR and luminescence) of new terbium and europium acylpyrazolonates

The synthesis and characterization of new lanthanide complexes of formulae [M(Q)₃(H₂O)(EtOH)], NBu₄[M(Q)₄] and [M(Q)₃(L)] (M = Eu or Tb; HQ = 1-phenyl-3-methyl-4-R-pyrazol-5-one: R = cyclopentylcarbonyl, HQ = HQ^CP; R = cyclopentylpropionyl, HQ = HQ^EtCP; L = 1,10-phenanthroline (phen) or 4,7-diphenyl-1,10-phenanthroline (bathophen)) are reported. The crystal structure of the tetrakis (β-diketonate) complex [NBu₄][Eu(Q^ETCP)₄] containing an eight-coordinated Eu atom in a distorted square antiprismatic environment has been determined. Luminescence studies have been performed on selected derivatives: the data suggested a strong influence of the nature of the acyl moiety in Q ligands and of Ph groups in bathophen (with respect to phen) on the luminescence properties.     

Synthesis and coordination behaviors of 14-membered tetraaza macrocyclic copper(II) complexes bearing two N-propionic acid or N-propionic methyl ester groups

A di-N-functionalized 14-membered tetraaza macrocycle, [H₄L³](ClO₄)₂ (L³ = 1,8-bis(2-carboxyethyl)-3,5,7,7,10,12,14,14-octamethyl-1,4,8,11-tetraazacyclotetradecane), has been synthesized by acid hydrolysis of 1,8-bis(2-cyanoethyl)-3,5,7,7,10,12,14,14-octamethyl-1,4,8,11-tetraazacyclotetradecane (L²). The copper(II) complexes [CuL²](ClO₄)₂ and [Cu(H₂L³)](ClO₄)₂ were prepared and characterized. The complex [Cu(H₂L³)]²⁺ readily reacts with methanol to yield [CuL⁴]²⁺ (L⁴ = 1,8-bis(2-carbomethoxyethyl)-3,5,7,7,10,12,14,14-octamethyl-1,4,8,11-tetraazacyclotetradecane). The N-CH₂CH₂COOH groups of [Cu(H₂L³)](ClO₄)₂ are not coordinated to the metal ion in the solid state but are involved in coordination in various non-aqueous solvents or in aqueous solutions of pH ? 1.0. Interestingly, [CuL⁴](ClO₄)₂ exists as two stable structural isomers, 1 (the pendant ester groups are not involved in coordination) and 2 (one of the two ester groups is coordinated to the metal ion), in the solid state; the two isomers can be prepared selectively by controlling ionic strength of a methanol solution of the complex. Crystal structures and coordination behaviors of the two isomers are described. The di-N-cyanoethylated macrocyclic complex [CuL²](ClO₄)₂ is rapidly decomposed in 0.1 M NaOH solution even at room temperature. On the other hand, [Cu(H₂L³)](ClO₄)₂ and [CuL⁴](ClO₄)₂ are quite inert against decomposition under similar basic conditions. In acidic or basic aqueous solutions, [CuL⁴]²⁺ is hydrolyzed to [Cu(H₂L³)]²⁺ or [CuL³].     

Preliminary chemico-biological studies on Ru(III) compounds with S-methyl pyrrolidine/dimethyl dithiocarbamate

[RuCl₃ · nH₂O] and Na(trans-[RuCl₄(DMSO)₂]) were reacted with 1-pyrrolidinedithiocarbamate (PDT), its S-methyl ester (PDTM), and N,N-dimethylcarbamodithioic acid methyl ester (DMDTM) in water or methanol in order to obtain the corresponding Ru(III) derivatives. Once isolated and purified, the complexes were characterized by means of elemental analysis, conductivity measurements, FT-IR and ¹H NMR spectroscopy, ion electrospray mass spectrometry (ESI-MS), and thermal analyses. The crystal structure of mer-[Ru(DMDTM)(DMSO)Cl₃] has been also determined by X-ray crystallography. In vitro cytotoxic activity of all the synthesized complexes was eventually evaluated on some selected human tumor cell lines.     

Isolation of substances with antiproliferative and apoptosis-inducing activities against leukemia cells from the leaves of Zanthoxylum ailanthoides Sieb. & Zucc

Extraction of the leaves of Zanthoxylum ailanthoides Sieb. & Zucc. affords extracts and four isolated compounds which exhibit activities against leukemia cells. The chloroform-soluble fraction (ZAC) of the crude extract of this plant showed cytotoxic activity against human promyelocytic leukemia (HL-60) and myelomonocytic leukemia (WEHI-3) cells with IC₅₀ values of 73.06 and 42.22 μg/mL, respectively. The active ZAC was further separated to yield pheophorbide-a methyl ester (1), pheophorbide-b methyl ester (2), 13²-hydroxyl (13²-S) pheophorbide-a methyl ester (3) and 13²-hydroxyl (13²-R) pheophorbide-b methyl ester (4) whose structures were confirmed by spectroscopic methods. Compounds 2-4 showed cytotoxic activities against both leukemia cells with IC₅₀ value in the range of 46.76-79.43 nM, whereas compound 1 exhibited only weak cytotoxic activity. The extracts and compounds 1-4 also induced apoptosis and DNA damage in leukemia cells after treatment. The results suggested that the Z. ailanthoides is biologically active against leukemia cells.     

High-performance liquid chromatography assay with fluorescence detection for the evaluation of inhibitors against human recombinant monoacylglycerol lipase

A fluorescent assay for the evaluation of inhibitors of monoacylglycerol lipase (MAGL) is described. 1,3-Dihydroxypropan-2-yl 4-pyren-1-ylbutanoate was designed and synthesized as novel fluorogenic substrate. Activity of human recombinant MAGL was determined in the presence of the surfactant Triton X-100 without further sample cleanup by measuring the amount of 4-pyren-1-ylbutanoic acid released by the enzyme with reversed-phase high-performance liquid chromatography (HPLC) and fluorescence detection. The known covalent binding MAGL inhibitors methyl arachidonyl fluorophosphonate (MAFP), 4-nitrophenyl 4-[bis(1,3-benzodioxol-5-yl)hydroxymethyl]piperidine-1-carboxylate (JZL184), and [4-(5-methoxy-2-oxo-1,3,4-oxadiazol-3-yl)-2-methylphenyl]carbamic acid benzyl ester (CAY10499) were used to validate the test system. Applying an incubation time of 15 min, the IC₅₀ values obtained for these compounds were 0.16, 3.7, and 1.1 μM, respectively. A prolongation of the incubation to 45 min results in a two- to threefold decrease of the IC₅₀ values.     

Simultaneous assay of isotopic enrichment and concentration of guanidinoacetate and creatine by gas chromatography-mass spectrometry

A gas chromatography-mass spectrometry (GC-MS) method for the simultaneous measurement of isotopic enrichment and concentration of guanidinoacetate (GAA) and creatine in plasma sample for kinetic studies is reported. The method, based on preparation of the bis(trifluoromethyl)pyrimidine methyl ester derivatives of GAA and creatine, is robust and sensitive. The lowest measurable m₁ and m₃ enrichment for GAA and creatine, respectively, was 0.3%. The calibration curves for measurements of concentration were linear over ranges of 0.5 to 250 μM GAA and 2 to 500 μM for creatine. The method was reliable for inter- and intraassay precision, accuracy, and linearity. The technique was applied in a healthy adult to determine the in vivo fractional synthesis rate of creatine using primed-constant rate infusion of [1-¹³C]glycine. It was found that isotopic enrichment of GAA reached a plateau by 30 min of infusion of [1-¹³C]glycine, indicating either a small pool size or a rapid turnover rate (or both) of GAA. In contrast, the tracer appearance in creatine was slow (slope = 0.00097), suggesting a large pool size and a slow rate of synthesis of creatine. This method can be used to estimate the rate of synthesis of creatine in vivo in human and animal studies.     

Syntheses, crystal structures, and magnetic properties of two cyclic dimer M2L2 complexes constructed from a new nitronyl nitroxide ligand and M(hfac)2 (M = Cu, Mn)

Two new binuclear radical complexes derived from a new long nitronyl nitroxide ligand, 2-[4-(5-pyrimidyl)phenyl]-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (4-NITPhPyrim), and M(hfac)₂ (M²⁺ = Cu²⁺, Mn²⁺; hfac⁻ = hexafluoroacetylacetonato), [Cu(hfac)₂(4-NITPhPyrim)]₂ · 4H₂O (1) and [Mn(hfac)₂(4-NITPhPyrim)]₂ · 4H₂O (2), were synthesized as well as characterized structurally and magnetically. X-ray analysis indicates that 1 and 2 are rectangle-like centrosymmetric dimer M₂L₂ complexes. Magnetic measurements indicate that there are two types of magnetic exchanges in 1: the ferromagnetic (FM) exchange between the Cu(II) ion and the directly bonded nitroxide unit (J₁ = 24.20 cm⁻¹) and the weak FM exchange of Cu-NIT through the pyrimidine and phenyl rings (J₂ = 0.62 cm⁻¹). Besides the strong antiferromagnetic (AFM) coupling between the Mn(II) ion and the directly bonded nitroxide unit (J = −87.61 cm⁻¹), there is a weak FM interaction between the two Mn-NIT pairs (θ = 0.39 K) in 2.     

Transition metal complexes (M = Cu, Ni and Mn) of Schiff-base ligands: Syntheses, crystal structures, and inhibitory bioactivities against urease and xanthine oxidase

Six new transition metal complexes (M = Cu(II), Ni(II) and Mn(III)) of tridentate (H₂L¹, HL²) and/or bidentate (HL³, HL⁴) Schiff-base ligands, obtained from the condensation of salicylaldehyde with glycine, N-(2-aminoethyl)morpholine, 4-(2-aminoethyl)phenylic acid and 4-(2-aminoethyl)benzsulfamide, respectively, were synthesized and structurally determined by single-crystal X-ray analysis. Complexes 1-6 were evaluated for their effect on the jack bean urease and xanthine oxidase (XO). Copper(II) complexes 1-3 (IC₅₀ = 0.43-2.25 μM) showed potent inhibitory activity against jack bean urease, comparable with acetohydroxamicacid (IC₅₀ = 42.12 μM), which is a positive reference. And these copper(II) complexes (IC₅₀ = 10.26-15.82 μM) also exhibited strong ability to inhibit activity of XO, comparable to allopurinol (IC₅₀ = 10.37 μM), which was used as a positive reference. Nickel(II) and manganese(III) complexes 4-6 showed weak inhibitory activity to jack bean urease (IC₅₀ = 4.36-8.25 μM) and no ability to inhibit XO (IC₅₀ > 100 μM).     

Interaction of Pt(II) and Pd(II) complexes of terpyridine with 1-methylazoles: A combined experimental and density functional study

The synthesis and characterization of several complexes of the composition [{M(terpy)}_n(L)](ClO₄)_m (M = Pt, Pd; L = 1-methylimidazole, 1-methyltetrazole, 1-methyltetrazolate; terpy = 2,2′:6′,2″-terpyridine; n = 1, 2; m = 1, 2, 3) is reported and their applicability in terms of a metal-mediated base pair investigated. Reaction of [M(terpy)(H₂O)]²⁺ with 1-methylimidazole leads to [M(terpy)(1-methylimidazole)](ClO₄)₂ (1: M = Pt; 2: M = Pd). The analogous reaction of [Pt(terpy)(H₂O)]²⁺ with 1-methyltetrazole leads to the organometallic compound [Pt(terpy)(1-methyltetrazolate)]ClO₄ (3) in which the aromatic tetrazole proton has been substituted by the platinum moiety. For both platinum(II) and palladium(II), doubly metalated complexes [{M(terpy)}₂(1-methyltetrazolate)](ClO₄)₃ (4: M = Pt; 5: M = Pd) can also be obtained depending on the reaction conditions. In the latter two compounds, the [M(terpy)]²⁺ moieties are coordinated via C5 and N4. X-ray crystal structures of 1, 2, and 3 are reported. In addition, DFT calculations have been carried out to determine the energy difference between fully planar [Pd(mterpy)(L)]²⁺ complexes Ip-IVp (mterpy = 4′-methyl-2,2′:6′,2″-terpyridine; L = 1-methylimidazole-N3 (I), 1-methyl-1,2,4-triazole-N4 (II), 1-methyltetrazole-N3 (III), or 3-methylpyridine-N1 (IV)) and the respective geometry-optimized structures Io-IVo. Whereas this energy difference is larger than 70 kJ mol⁻¹ for compounds I, II, and IV, it amounts to only 0.8 kJ mol⁻¹ for the tetrazole-containing complex III, which is stabilized by two intramolecular C-H?N hydrogen bonds. Of all complexes under investigation, only the terpyridine-metal ion-tetrazole system with N3-coordinated tetrazole appears to be suited for an application in terms of a metal-mediated base pair in a metal-modified oligonucleotide.     

Synthesis, structure and magnetic property of μ-phenoxo-μ-acetato-bis(η-acetato)dicobalt(II, II) complexes

Dinuclear cobalt(II) complexes Co₂(bpmp)(OAc)₃ (1) and Co₂(bpcp)(OAc)₃ (2) have been synthesized by using acyclic ligands 2,6-bis((4-(pyridin-2-yl)pyrimidin-2-ylthio)methyl)-4-methylphenol [H(bpmp)] and 2,6-bis((4-(pyridin-2-yl)pyrimidin-2-ylthio)methyl)-4-chlorophenol [H(bpcp)] with versatile coordination sites. X-ray analysis uncovered that complex 1 · 3H₂O contains a μ-phenoxo-μ-acetato-bis(η²-acetato) dicobalt(II, II) core. Magnetic susceptibility was measured for 1 over the temperature range 1.8-300 K, and the best theoretical fitting parameters were g = 2.12(6), J = −3.63(9) cm⁻¹ and D = −12(4) cm⁻¹.     

Rhenium(III) and technetium(III) complexes with 2-mercapto-1,3-azole ligands and X-ray crystal structures

Reactions of labile [MCl₃(PPh₃)₂(NCMe)] (M = Tc, Re) precursors with 1H-benzoimidazole-2-thiol (H₂L¹), 5-methyl-1H-benzoimidazole-2-thiol (H₂L²) and 1H-imidazole-2-thiol (H₂L³), in the presence of PPh₃ and [AsPh₄]Cl gave a new series of trigonal bipyramidal M(III) complexes [AsPh₄]{[M(PPh₃)Cl(H₂L^1-3)₃]Cl₃} (M = Re, 1-3; M = Tc, 4-6). The molecular structures of 1 and 3 were determined by X-ray diffraction. When the reactions were carried out with benzothiazole-2-thiol (HL⁴) and benzoxazole-2-thiol (HL⁵), neutral paramagnetic monosubstituted M(III) complexes [M(PPh₃)₂Cl₂(L^4,5)] (M = Re, 8, 9; M = Tc, 10, 11) were obtained. In these compounds, the central metal ions adopt an octahedral coordination geometry as authenticated by single crystal X-ray diffraction analysis of 8 and 11. Rhenium and technetium complexes 1, 4 and rhenium chelate compounds 8, 9 have been also synthesized by reduction of [MO₄]⁻ with PPh₃ and HCl in the presence of the appropriate ligand. All the complexes were characterized by elemental analyses, FTIR and NMR spectroscopy.     

Discrete and 1D coordination polymeric chloro-bridged copper(II) dimers exhibiting ferro- and antiferromagnetic exchange coupling: Magneto-structural correlations and non-covalent interactions

The synthesis and characterization of two 1D coordination polymers [Cu₂(MHL)Cl₂][ClO₄]₂ · CH₃CN · THF (2 · CH₃CN · THF) and [Cu₂(MPyPz)Cl₂][ClO₄]₂ · CH₃CN (3 · CH₃CN), having repetitive units, of m-xylyl-based ligands with terminal tridentate (2-pyridyl)alkylamine (MHL = α,α′-bis[N-(2-pyridylethyl)-N-(2-pyridylmethyl)amino]-m-xylene) and (2-pyridyl)alkylamine/pyrazole (MPyPz = α,α′-bis[N-(2-pyridylethyl)-N-(pyrazol-1-ylmethyl)amino]-m-xylene) coordination have been accomplished. X-ray crystallographic studies reveal that the copper(II) centers in the recently reported dichloro-bridged discrete complex [{Cu(MeL)Cl}₂][ClO₄]₂ (1) of a tridentate (2-pyridyl)alkylamine ligand [MeL = methyl[2-(2-pyridyl)ethyl](2-pyridylmethyl)amine], 2 · CH₃CN · THF, and 3 · CH₃CN have distorted square-pyramidal geometry, sharing a base-to-apex edge with parallel basal planes. Variable-temperature susceptibility measurements in the range of 2-300 K reveal antiferromagnetic for 1 [J (singlet-triplet energy gap) = −3.89 cm⁻¹] and 2 · CH₃CN · THF (J = −1.84 cm⁻¹), and ferromagnetic for 3 · CH₃CN (J = +6.27 cm⁻¹) coupling. The complexes provide useful information for the magneto-structural correlations.